Dementia

• FDA approval · 2014-03-19
  FDA Approved: NEURACEQ — Original Application (Lantheus Biosciences Ltd.)

  FDA approved NEURACEQ (florbetaben F-18) for PET imaging to estimate beta-amyloid neuritic plaque density in adults with cognitive impairmen…

• FDA approval · 2014-02-05
  FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Washington University School of Medicine)

  FDA approves the original application for Fludeoxyglucose F-18 (FDG F-18), a radiopharmaceutical used in PET imaging to localize abnormal me…

• FDA approval · 2013-10-25
  FDA Approved: VIZAMYL — Original Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))

  FDA approved Vizamyl (flutemetamol F-18) under an original application as a PET imaging agent to detect beta-amyloid plaques in adult patien…

• FDA approval · 2013-08-05
  FDA Approved: CERETEC — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

  FDA approves a supplemental application for CERETEC (TECHNETIUM TC-99M EXAMETAZIME) from Medi-Physics Inc. dba GE Healthcare.